Provided by Tiger Trade Technology Pte. Ltd.

Bristol-Myers Squibb

58.67
-1.3100-2.18%
Volume:1.33M
Turnover:78.51M
Market Cap:119.44B
PE:16.96
High:59.20
Open:59.15
Low:58.61
Close:59.98
52wk High:62.89
52wk Low:42.52
Shares:2.04B
Float Shares:2.03B
Volume Ratio:1.16
T/O Rate:0.07%
Dividend:2.49
Dividend Rate:4.24%
EPS(TTM):3.46
EPS(LYR):3.46
ROE:40.44%
ROA:10.29%
PB:6.47
PE(LYR):16.96

Loading ...

Bristol Myers Squibb call volume above normal and directionally bullish

TIPRANKS
·
Mar 04

Prime Medicine Publishes Corporate Presentation on Prime Editing Platform and Gene-Editing Pipeline

Reuters
·
Mar 03

Prime Medicine posts FY 2025 collaboration revenue of USD 4.6 million, up 2.9x

Reuters
·
Mar 03

Protagenic Therapeutics Names William Nichols Jr. President

Reuters
·
Mar 03

Bristol-Myers Squibb Keeps Quarterly Dividend at $0.63 a Share, Payable May 1 to Shareholders of Record on April 2

MT Newswires Live
·
Mar 03

Bristol Myers Squibb announces $0.63 per-share dividend

Reuters
·
Mar 03

Bristol Myers Squibb Announces Dividend

THOMSON REUTERS
·
Mar 03

Barclays Names Eli Lilly (LLY) and Bristol-Myers Squibb (BMY) as Top Pharma Stocks to Buy Now

TIPRANKS
·
Mar 01

Bristol Myers Squibb Co. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Feb 28

Janux Therapeutics Q4 net loss widens on higher R&D expenses

Reuters
·
Feb 27

Bristol Myers Says New Breast Cancer Drug Shows Survival Benefit In Pretreated Patients

Benzinga_recent_news
·
Feb 27

Is Bristol Myers Squibb (BMY) Pricing In Its 2024 Results And Product Pipeline Outlook?

Simply Wall St.
·
Feb 27

Bristol Myers Squibb reports Phase III interim wins for iza-bren in advanced TNBC

Reuters
·
Feb 26

Berenberg Bank Keeps Their Hold Rating on Bristol-Myers Squibb (BMY)

TIPRANKS
·
Feb 26

Bristol-Myers Squibb's Risk/Reward Profile Balanced, RBC Says

MT Newswires Live
·
Feb 26

Bristol-Myers Squibb Advances Pediatric Lymphoma Combo, Signaling Quiet Upside for BMY Investors

TIPRANKS
·
Feb 26

A Look At Bristol Myers Squibb (BMY) Valuation After Recent Reblozyl And Iberdomide Milestones

Simply Wall St.
·
Feb 25

Bristol-Myers Squibb Initiated at Sector Perform by RBC Capital

Dow Jones
·
Feb 25

NYSE Content Update: Two MSCI Indexes to Begin Trading on NYSE Arca Options

prnewswire
·
Feb 25

Berenberg Lifts Price Target on Bristol-Myers Squibb to $60 From $57, Keeps Hold Rating

MT Newswires Live
·
Feb 25